Peripheral blood progenitor cells for HPC transplants involving unrelated donors.
Stroncek
D F
DF
Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, USA. dstroncek@dtm.cc.nih.gov
Confer
D L
DL
Leitman
S F
SF
D000925:Anticoagulants / Q000009:adverse effects; D018952:Antigens, CD34 / Q000032:analysis; D001772:Blood Cell Count / Q000187:drug effects; D001781:Blood Component Removal / Q000379:methods; D016026:Bone Marrow Transplantation / Q000276:immunology / Q000639:trends; D019343:Citric Acid / Q000009:adverse effects; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000494:pharmacology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000494:pharmacology; D019650:Hematopoietic Stem Cell Mobilization / Q000009:adverse effects; D018380:Hematopoietic Stem Cell Transplantation / Q000639:trends; D006648:Histocompatibility; D006801:Humans; D007938:Leukemia / Q000139:chemically induced / Q000453:epidemiology; D007970:Leukopenia / Q000209:etiology; D011994:Recombinant Proteins / Q000009:adverse effects / Q000494:pharmacology; D012449:Safety; D014019:Tissue Donors; D014184:Transplantation, Homologous
D000925:Anticoagulants; D018952:Antigens, CD34; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D019343:Citric Acid; D016178:Granulocyte-Macrophage Colony-Stimulating Factor